Form D · Other Health Care
BrainScope Company, Inc.
Bethesda, MD · CIK 0001369576
Offering snapshot reported Sep 29, 2017 · SEC filing
- Reported sold
- $16.4M Offering amount: $16.4M
- Investors reported
- 38 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 5, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 29, 2017 | Initial | $16,386,250 | No comparison | 38 | SEC filing |
| Sep 3, 2015 | Initial | $2,465,000 | No comparison | 12 | SEC filing |
| Sep 3, 2015 | Amendment | $16,500,000 | $10,925,000vs Nov 15, 2011 | 43 | SEC filing |
| Nov 15, 2011 | Amendment | $5,575,000 | $3,975,000vs Dec 27, 2010 | 19 | SEC filing |
| Dec 27, 2010 | Initial | $1,600,000 | No comparison | 4 | SEC filing |
| Mar 16, 2010 | Initial | $2,400,000 | No comparison | 4 | SEC filing |
| Jan 11, 2010 | Initial | $385,000 | No comparison | 3 | SEC filing |
| Dec 2, 2009 | Initial | $970,000 | No comparison | 3 | SEC filing |
| Oct 30, 2009 | Initial | $1,593,750 | No comparison | 9 | SEC filing |
| Jul 6, 2009 | Initial | $1,500,000 | No comparison | 4 | SEC filing |
| Jan 12, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 8, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 27, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 27, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 21, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 5, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-295689
Source: Form D, filed Sep 29, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Moshe Alafi | Director |
| Jean Case | Director |
| Steve Case | Director |
| Miles R. Gilburn | Director, Executive |
| Miles Gilburne | Director |
| Phillip E. Himelstein | Director |
| Andrew Holman | Executive |
| Daniel Moore | Director |
| James Peake | Director |
| John M. Reher | Director |
| Cynthia Ringo | Director |
| Kerstin Schultz | Executive |
| Laurie Silver | Executive |
| Michael E. Singer | Director, Executive |
| Gail Wilensky | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
4350 East West Highway Suite 1050
Bethesda, MD, 20814
Bethesda, MD, 20814